•
Mar 31, 2012

ResMed Q3 2012 Earnings Report

Total Revenue
$349M
Previous year: $901M
-61.3%
EPS
$0.44
Previous year: $0.35
+25.7%
Gross Profit
$210M
Previous year: $542M
-61.2%
Cash and Equivalents
$776M
Previous year: $672M
+15.5%
Free Cash Flow
$76.1M
Previous year: $65.4M
+16.5%
Total Assets
$2.13B
Previous year: $1.96B
+8.5%

ResMed

ResMed